OPTN and sarcoma: Mutations in six genes can explain about 60–70% of fALS and about 10% of sALS cases: SOD1, TARDBP, FUS (fused in sarcoma), VCP (valosin-containing protein), OPTN (optineurin), and C9orf72 [4,9].